Suraiya Anjum Ansari

Therapeutic potential of Mediator complex subunits in metabolic diseases.

Identification of early indicators of altered metabolism in normal development using a rodent model system.

Saturated fatty acid alters embryonic cortical neurogenesis through modulation of gene expression in neural stem cells.

Neuroprotective Effects of Thymol, a Dietary Monoterpene Against Dopaminergic Neurodegeneration in Rotenone-Induced Rat Model of Parkinson's Disease.

The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus.

Stem cell fate determination through protein O-GlcNAcylation.

Epigenetic modifications in pancreas development, diabetes, and therapeutics.

The epigenetic-metabolic interplay in gliomagenesis.

Nutrient sensitive protein -GlcNAcylation modulates the transcriptome through epigenetic mechanisms during embryonic neurogenesis.

Developmental modeling of hepatogenesis using obese iPSCs-hepatocyte differentiation uncovers pathological features.

DNA methylation in the pathogenesis of type 2 diabetes.

Maternal Diabetes Deregulates the Expression of Mecp2 via miR-26b-5p in Mouse Embryonic Neural Stem Cells.

O-GlcNAc transferase promotes glioblastoma by modulating genes responsible for cell survival, invasion, and inflammation.

Reappraisal of the Concept of Accelerated Aging in Neurodegeneration and Beyond.

The Long Non-Coding RNA Obesity-Related (Obr) Contributes To Lipid Metabolism Through Epigenetic Regulation.

Exploring histone deacetylases in type 2 diabetes mellitus: pathophysiological insights and therapeutic avenues.

Opening and changing: mammalian SWI/SNF complexes in organ development and carcinogenesis.